Literature DB >> 23163881

In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.

Lorenzo Albertazzi1, Lisa Gherardini, Marco Brondi, Sebastian Sulis Sato, Angelo Bifone, Tommaso Pizzorusso, Gian Michele Ratto, Giuseppe Bardi.   

Abstract

Dendrimers have been described as one of the most tunable and therefore potentially applicable nanoparticles both for diagnostics and therapy. Recently, in order to realize drug delivery agents, most of the effort has been dedicated to the development of dendrimers that could internalize into the cells and target specific intracellular compartments in vitro and in vivo. Here, we describe cell internalization properties and diffusion of G4 and G4-C12 modified PAMAM dendrimers in primary neuronal cultures and in the CNS of live animals. Confocal imaging on primary neurons reveals that dendrimers are able to cross the cell membrane and reach intracellular localization following endocytosis. Moreover, functionalization of PAMAMs has a dramatic effect on their ability to diffuse in the CNS tissue in vivo and penetrate living neurons as shown by intraparenchymal or intraventricular injections. 100 nM G4-C12 PAMAM dendrimer already induces dramatic apoptotic cell death of neurons in vitro. On the contrary, G4 PAMAM does not induce apoptotic cell death of neural cells in the sub-micromolar range of concentration and induces low microglia activation in brain tissue after a week. Our detailed description of dendrimer distribution patterns in the CNS will facilitate the design of tailored nanomaterials in light of future clinical applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23163881     DOI: 10.1021/mp300391v

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  33 in total

Review 1.  Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.

Authors:  David J Mc Carthy; Meenakshi Malhotra; Aoife M O'Mahony; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

Review 2.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

3.  Targeting, endocytosis, and lysosomal delivery of active enzymes to model human neurons by ICAM-1-targeted nanocarriers.

Authors:  Janet Hsu; Janet Hoenicka; Silvia Muro
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

4.  Manganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis.

Authors:  Tuyen H Nguyen; Henry Bryant; Ari Shapsa; Hannah Street; Venkatesh Mani; Zahi A Fayad; Joseph A Frank; Sotirios Tsimikas; Karen C Briley-Saebo
Journal:  J Magn Reson Imaging       Date:  2014-03-10       Impact factor: 4.813

5.  Atomistic computer simulations on multi-loaded PAMAM dendrimers: a comparison of amine- and hydroxyl-terminated dendrimers.

Authors:  Farideh Badalkhani-Khamseh; Azadeh Ebrahim-Habibi; Nasser L Hadipour
Journal:  J Comput Aided Mol Des       Date:  2017-12-19       Impact factor: 3.686

Review 6.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

7.  Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina.

Authors:  Siva P Kambhampati; Alexander J M Clunies-Ross; Imran Bhutto; Manoj K Mishra; Malia Edwards; D Scott McLeod; Rangaramanujam M Kannan; Gerard Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

8.  Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.

Authors:  Elizabeth Nance; Fan Zhang; Manoj K Mishra; Zhi Zhang; Siva P Kambhampati; Rangaramanujam M Kannan; Sujatha Kannan
Journal:  Biomaterials       Date:  2016-05-26       Impact factor: 12.479

Review 9.  Intrathecal drug delivery in the era of nanomedicine.

Authors:  M J Fowler; J D Cotter; B E Knight; E M Sevick-Muraca; D I Sandberg; R W Sirianni
Journal:  Adv Drug Deliv Rev       Date:  2020-03-03       Impact factor: 15.470

Review 10.  Dendrimer advances for the central nervous system delivery of therapeutics.

Authors:  Leyuan Xu; Hao Zhang; Yue Wu
Journal:  ACS Chem Neurosci       Date:  2013-12-05       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.